UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US.
The gastrointestinal (GI) diagnostic company’s EndoSign...
Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO).
The Tucson, Arizona–based...
Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology.
The Brisbane, Australia-based company picked up about $32...
Avasa completed the first close of its pre-Series A fundraising round worth about $2.8 million (NZD$4.75 million).
Movac, one of New Zealand’s largest and longest-standing...
ProVerum Limited, the developer of the ProVee System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced the closing of...
Terumo entered into a definitive agreement to acquire OrganOx and its organ preservation technology.
Tokyo-based Terumo agreed to acquire all outstanding OrganOx shares for approximately...
Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners Group.
The agreement sees Partners Group acquire a...
Method AI announced it raised $20 million in Series A funding to support its novel surgical ultrasound platform.
The Boston-based company, co-founded by former Corindus...